Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Kucukoglu, Mehmet; HANTA, İSMAİL; AKDENİZ, BAHRİ; Gullulu, Sumeyye; Atahan, Ersan; SAYIN, TAMER; Okumus, Nigar; ÖNEN, ZEYNEP; Yokusoglu, Mehmet; Baygul, Arzu

doi:10.5152/anatoljcardiol.2021.03009

Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Copy For Citation

Kucukoglu M. S., HANTA İ., AKDENİZ B., Gullulu S., Atahan E., SAYIN T., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.25, no.10, pp.721-732, 2021 (SCI-Expanded)

Publication Type: Article / Article
Volume: 25 Issue: 10
Publication Date: 2021
Doi Number: 10.5152/anatoljcardiol.2021.03009
Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
Page Numbers: pp.721-732
Keywords: pulmonary arterial hypertension, iloprost, treatment outcome, safety, survival, COMBINATION THERAPY, ORAL SILDENAFIL, TARGETED DRUGS, NITRIC-OXIDE, PROSTACYCLIN, METAANALYSIS, INSIGHTS
Istanbul University Affiliated: Yes

Abstract

Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost treatment in the daily practice for the management of pulmonary arterial hypertension (PAH).